Preventing Morbidity in First Episode Schizophrenia, Part II.

Trial Profile

Preventing Morbidity in First Episode Schizophrenia, Part II.

Phase of Trial: Phase IV

Latest Information Update: 15 Sep 2016

At a glance

  • Drugs Aripiprazole (Primary) ; Risperidone (Primary)
  • Indications Psychotic disorders; Schizoaffective disorder; Schizophrenia
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Jan 2016 Status changed from active, no longer recruiting to completed as per record.
    • 13 May 2015 Planned End Date changed from 1 Oct 2015 to 1 Dec 2015 as per record.
    • 29 May 2013 Planned end date changed from 1 Oct 2013 to 1 Oct 2015 as reported by
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top